Otolaryngology · Philadelphia, PA
NPI
1033127006
Since 2006
Specialty
Otolaryngology
Code 207Y00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3400 Spruce Street, 5 Silverstein Building
Philadelphia, PA, 19104
Phone (215) 662-2777
Groups this clinician bills Medicare through
Medicare paid, 2024
$93K
2,252 services
Medicare patients, 2024
253
Average age 72
Drug cost, 2024
$693K
1,896 prescriptions
Company payments, 2025
$20.9
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert T Adelson was code 95117 (treatment - miscellaneous), 283 times for 14 patients. In total Robert T Adelson billed 2,252 services in 41 codes, and Medicare paid $93K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-05-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95117 Treatment - Miscellaneous | Office | 283 | 14 | $8.41 | $2,381 |
| 31231 Nasal/Sinus Endoscopy | Office | 281 | 193 | $123.93 | $35K |
| 99213 Office E&M - Established | Office | 187 | 132 | $65.08 | $12K |
| 99214 Office E&M - Established | Office | 111 | 87 | $91.47 | $10K |
| 77011 Conventional Radiation Treatment | Office | 35 | 35 | $161.64 | $5,657 |
| 31237 Nasal/Sinus Endoscopy | Office | 24 | 15 | $211.23 | $5,070 |
| 99204 Office E&M - New | Office | 13 | 13 | $119.38 | $1,552 |
By year: 2022 $126K for 2,093 services; 2023 $108K for 1,814 services; 2024 $93K for 2,252 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert T Adelson prescribed most often to Medicare patients was Budesonide, with 380 prescriptions and refills. In total Robert T Adelson wrote 1,896 Medicare prescriptions that cost $693K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Budesonide Generic | 380 | 708 | 123 | $123K |
| Ipratropium Bromide Generic | 179 | 257 | 52 | $6,308 |
| Xhance Fluticasone Propionate | 139 | 205 | 47 | $119K |
| Montelukast Sodium Generic | 122 | 315 | 36 | $1,631 |
| Mometasone Furoate Generic | 90 | 187 | 33 | $11K |
| Levocetirizine Dihydrochloride Generic | 89 | 237 | 30 | $1,591 |
| Fluticasone Propionate Generic | 88 | 171 | 40 | $1,670 |
| Dupixent Pen Dupilumab | 82 | 91 | Under 11 | $335K |
| Azelastine Hcl Generic | 82 | 151 | 33 | $3,235 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 82 | 82 | 68 | $1,001 |
| Olopatadine Hcl Generic | 80 | 104 | 26 | $7,375 |
| Desloratadine Generic | 70 | 141 | 24 | $2,639 |
| Famotidine Generic | 56 | 123 | 19 | $590 |
| Prednisone Generic | 55 | 55 | 49 | $259 |
| Doxycycline Hyclate Generic | 47 | 47 | 33 | $523 |
Brand drugs: 266 claims; generic drugs: 1,630 claims; opioid claims: 20.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert T Adelson $20.9 ($20.9 in general payments such as food, travel and fees) from 1 company. The largest payer was Jazz Pharmaceuticals Inc. with $20.9.
| Company | Payments | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $20.9 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.